Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03487146
Other study ID # ShanghaiPudongH1
Secondary ID
Status Completed
Phase N/A
First received March 26, 2018
Last updated April 3, 2018
Start date May 1, 2015
Est. completion date December 1, 2017

Study information

Verified date March 2018
Source Shanghai Pudong Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Sleep disturbance has been long-standing torments in most of patients with maintenance hemodialysis (HD). In this study, we attempted to explore whether long-term hemoperfusion (HP) could improve sleep disorder and increase overall survival rate in HD patients.


Recruitment information / eligibility

Status Completed
Enrollment 156
Est. completion date December 1, 2017
Est. primary completion date August 1, 2017
Accepts healthy volunteers No
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria:

1. duration of maintenance HD should be equal or more than 3 months,

2. patient's age should be equal or more than 18 years

Exclusion Criteria:

- i) he/she diagnosed with malignant tumors, an active rheumatism, infectious diseases, or a severe heart failure ii) he/she would disagree with the study

3. he/she has received a short-term poor prognosis

4. he/she would be more than 80 years old

Study Design


Related Conditions & MeSH terms


Intervention

Device:
hemoperfusion(HP)
These patients were computer-matched into two groups, involving 100 patients with absolute HD vs. 100 cases with HD+HP.HP was performed 1-2 times/per 2 weeks, and each session lasted for two hours.Self-reported sleep disturbance was evaluated before and after observational time (two-year period), which lasted at least 7 hours based on the recommendations presented by National Institute of Health (NIH). Sleep efficiency (%) was calculated as the ratio of sleep duration to total time in bed, and was multiplied by 100.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Shanghai Pudong Hospital

Outcome

Type Measure Description Time frame Safety issue
Primary improvement of self-reported sleep disturbance Analysis of the sleep disturbance by using Pittsburgh Sleep Quality Index (PSQI) questionnaire 2 years
Secondary survival increase overall survival rate 2 years
See also
  Status Clinical Trial Phase
Completed NCT04643639 - Assessing the Effects of CytoSorb Hemoperfusion on the Development on Immunoparalysis Phase 3
Not yet recruiting NCT05044403 - Evaluation of the Efficacy and Safety of Extracorporeal Support With Hemoperfusion in Critical Patients With Multiorgan Dysfunction Syndrome by Septic Origin Phase 4
Completed NCT02461953 - Combination of Hemodialysis With Hemoperfusion:A Clinical Study N/A